Business

Additional complete responses in CHM CORE-NK Phase 1b trial

Additional complete responses in CHM CORE-NK Phase 1b trial

Chimeric Therapeutics LimitedOctober 2, 20253

Additional complete responses in CHM CORE-NK Phase 1b trial

About this update from Chimeric Therapeutics Limited

Chimeric Therapeutics Ltd has released a press release. View Attachment

View stock analysis, news, and events for Chimeric Therapeutics Limited

More from Chimeric Therapeutics Limited

CHM ceases enrolment in Phase 1 trial and Company update

August 18, 2026

Chimeric receives $1.62M advance on FY26 R&D tax incentive

July 29, 2026

All Chimeric Therapeutics Limited news →